Literature DB >> 27407502

Psychiatric Manifestations in three cases of Acute Intermittent Porphyria.

Neatu Narang1, A Banerjee2, J Kotwal3, Jasmeet Kaur4, Y V Sharma5, C S Sharma6.   

Abstract

Keywords:  Acute Intermittent Porphyria; Delta-Aminolevulinic Acid; Organic Psychotic Disorder; Porphobilinogen

Year:  2011        PMID： 27407502      PMCID： PMC4923792          DOI： 10.1016/S0377-1237(03)80075-8

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  5 in total

Review 1.  Laboratory investigation of the porphyrias.

Authors:  G H Elder; S G Smith; S J Smyth
Journal:  Ann Clin Biochem       Date:  1990-09       Impact factor: 2.057

2.  Advances in understanding and treating 'the little imitator,' acute porphyria.

Authors:  H L Bonkovsky
Journal:  Gastroenterology       Date:  1993-08       Impact factor: 22.682

Review 3.  Acute porphyrias: pathogenesis of neurological manifestations.

Authors:  U A Meyer; M M Schuurmans; R L Lindberg
Journal:  Semin Liver Dis       Date:  1998       Impact factor: 6.115

4.  Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases.

Authors:  R Kauppinen; P Mustajoki
Journal:  Medicine (Baltimore)       Date:  1992-01       Impact factor: 1.889

Review 5.  Free radicals involvement in neurological porphyrias and lead poisoning.

Authors:  H P Monteiro; E J Bechara; D S Abdalla
Journal:  Mol Cell Biochem       Date:  1991-04-24       Impact factor: 3.396
  5 in total
  1 in total

1.  Severe hydroxymethylbilane synthase deficiency causes depression-like behavior and mitochondrial dysfunction in a mouse model of homozygous dominant acute intermittent porphyria.

Authors:  Stefanie Berger; Miranda Stattmann; Ana Cicvaric; Francisco J Monje; Pierluca Coiro; Matej Hotka; Gerda Ricken; Johannes Hainfellner; Susanne Greber-Platzer; Makiko Yasuda; Robert J Desnick; Daniela D Pollak
Journal:  Acta Neuropathol Commun       Date:  2020-03-20       Impact factor: 7.801
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.